galileo logo
The Company
management team
board of directors
the technology
the market
News
Employment
Contact
Home

Board of Directors

Douglas W. Lehrman

Mr. Lehrman has served as Director since July 2000. Mr. Lehrman is Managing Director at North Castle Partners, LLC in Greenwich, Connecticut. For 17 years prior to founding North Castle with his partners in 1998, Mr. Lehrman was an investment banker specializing in leveraged buyouts.  During that career he was involved with over 50 transactions with a total value of approximately $8 billion. Much of Mr. Lehrman's focus was developing new sources of private capital for growth-oriented companies to achieve their business plans. His focus at North Castle includes Grand Expeditions, its global travel company, a variety of early stage investments including Galileo Laboratories, and Healthnotes, in addition to opportunities in the food, health information and other sectors.

Craig C. Taylor

Mr. Taylor has served as  Director since January 1998. Mr. Taylor is a General Partner of Alloy Ventures, formerly Asset Management, and partner of AMC Partners 89, L.P. Mr. Taylor has been with Asset Management, a venture management group, since 1977. Mr. Taylor is currently a Director of Telor Ophthalmic Pharmaceuticals, Inc., Metra BioSystems, Inc., Lynx Therapeutics, Inc., Pharmacyclics, Inc. and of several private companies. Mr. Taylor holds BS and MS degrees in physics from Brown University and an MBA from Stanford University Graduate School of Business.

Roger Salquist

Mr. Salquist has served as Director since May 1999. Mr. Salquist is a Partner and Managing Director of Bay City Capital ("BCC"), a San Francisco-based merchant bank. BCC is the Advisor and Mr. Salquist is the Chief Investment Officer of the North American Nutrition and Agribusiness Fund, which invests in high-growth-potential companies engaged in technological and business innovation in the nutrition and agribusiness sectors. From 1984 through 1996, Mr. Salquist served as Chairman and Chief Executive Officer of Calgene, Inc. Mr. Salquist currently serves as a Director of Akkadix Corporation, Lifespring, and OmegaTech, Inc. Mr. Salquist is a trustee of the Fidelity Investments Charitable Gift Fund and a member of the Board of Trustees of the University of San Francisco. Mr. Salquist holds a BA and an MBA from Stanford University.

Richard A. Miller, MD

Dr. Miller has served as  Director since January of 1998. Dr. Miller is the President, Chief Executive Officer and a Director of Pharmacyclics, Inc., a public biotechnology company, which he co-founded in April 1991. In 1984, Dr. Miller co-founded IDEC Pharmaceuticals Corporation, a public biotechnology company, where he served as Vice President and a director until February 1992. Dr. Miller also is Clinical Professor of Medicine (Oncology) at Stanford University Medical Center. Dr. Miller received his MD, summa cum laude, from the State University of New York Medical School and is board certified in both Internal Medicine and Medical Oncology.

Terry Gould

Mr. Gould has served as Director since January 1998. Mr. Gould is Executive Director, Direct Investment Team at UBS Brinson. Prior to joining UBS Brinson, Mr. Gould was with Trinity Ventures, Ltd. Earlier in his career, Mr. Gould spent five years as a management consultant, including at the Boston and San Francisco offices of the Boston Consulting Group Inc., an international strategy-consulting firm. Mr. Gould also was a founder of and manager in two successful, entrepreneurial companies, Innovative Leisure and Viasoft. Mr. Gould currently is a Director of Allegis Corporation (formerly Net-It Software) and Network Integrity, Inc. Mr. Gould holds a BA from Dartmouth College and an MBA from the Stanford University Graduate School of Business.

Vicente Anido, PhD

Dr. Anido has served as Director since December 1998. Most recently he served as Chief Executive Officer of CombiChem, Inc. Prior to CombiChem, Inc., Dr. Anido was the President of the Americas Region at Allergan, Inc., where he was responsible for the company's commercial operations in North and South America. Prior to Allergan, Dr. Anido spent approximately 18 years at Marion Laboratories and Marion Merrell Dow. Dr. Anido holds BS and MS degrees in pharmacy and pharmaceutical sciences from West Virginia University and a PhD from the University of Missouri.

Guy Miller, MD, PhD

Dr. Miller, founder and Chief Executive Officer of Galileo Laboratories, serves also as Chairman of the Board of Directors. Before forming Galileo, Dr. Miller was Associate Professor at Johns Hopkins Medical Institutions School of Medicine. After completing a Surgical Internship at the University of Chicago, he completed a residency in Anesthesiology & Critical Care Medicine and a Fellowship in Multidisciplinary Critical Care Medicine at Johns Hopkins. Currently, Dr. Miller is Clinical Instructor, Stanford University School of Medicine. Dr. Miller holds an MD from the Medical College of Pennsylvania and a PhD in Chemistry from the University of Virginia.

 

Buy neurontin cod


Neurontin Cream For Vulvodynia
5-5 stars based on 865 reviews

Neurontin to buy it. The company claims that it has a lot of expertise in developing anti-ageing products to promote healthy appearance, but since age is simply a factor of probability, there is no reason why the system couldn't have been easily modified by anyone with basic programming knowledge. The claim was made back in 2010, after the system had achieved about 85% of its intended lifespan. There is a reason why so many "ageing" products have failed Buy silagra to produce the kind of results they promised. were not developed by an outside laboratory and were not made on a neurontin buy online higher level standard that was supposed to guarantee results. Another example is Biosil, an anti-ageing skin cream which claims to preserve skin's youthful appearance and skin elasticity. Soylent Brown Soylent is a drink mix consisting of three different nutrients and is supposed to help replace human needs for energy and nutrients. The first two can be consumed as liquid and the last can be consumed as a powder. Neurontin 120 pills 40 mg - 205.27$ For three months starting last August, Soylent Brown gave out 1,957,000,000 calories (equal to the current global energy needs of 6.25 billion people), with a calorie equivalent of 400,000,000 calories if not combined with a healthy diet. Now, let me be clear: the daily volume for 200,000 Soylent-users doesn't amount to what's normally available for a single individual. But these figures also don't tell the whole story of magnitude food production in the world. Soylent was Tahor générique france launched with an impressive $3.7 million of financing from Google-founder Eric Schmidt. The idea behind Soylent is to bring the idea of eating as a substitute for food closer to popular taste than it would be otherwise. The company has been claiming that the diet is so easy, anyone, regardless of physical shape and size,, can eat the way they want to and lose weight in a matter of days. But more careful analysis of the numbers suggests that Soylent is offering an unrealistic target of reducing population growth by a mere 0.2%. In 2014, one of its early beta testers had the remarkable observation that his own Soylent intake gave him a "nutritional boost without any of the nutritional risk". Another claim is that the mixture also lowers blood sugar and cholesterol — the same claims food industry makes while advertising products that are high in sugar, saturated fats and cholesterol, but don't necessarily contain sugar and saturated fats in any realistic amount. Soylent appears to be the product of an industry trying to get out of the way to focus on a different target. According to Soylent's site, the product is designed as an "efficient, sustainable vehicle for food production" by "divergent thinkers looking beyond today's food system to a world that will never again require such wasteful inputs and waste of agricultural land". That seems to be something like the future of food. Not really a healthy solution for everyone, but certainly not a problem the world will be trying to solve immediately. But will we actually be eating a diet that is even shorter as it now when we have the ability to use technology produce food much more efficiently than could ever be possible before? Soylent is not the only dubious food item being sold with claims of "anti-ageing" benefits. The Soylent brand has also featured products using the term "low-carbohydrates" in its marketing to target the growing number of "weight loss" enthusiasts. That includes the book One Week to Start Living Better, which encourages readers to eat "sugar free" foods after only one day of dieting to lose weight and then gradually eat more carbs the they change their diet, and the new cookbook Protein Power Houseby the company Krave Labs, which features recipes written to show you how make a protein-boosting smoothie using nothing but kale, spinach, black discount code for pharmacy online 365 beans and pinto beans. The book also notes that benefits of adding a protein-full meal is the same as weight loss.

  • Boston
  • Wittstock
  • Friesoythe
  • Neurontin Wahlstedt
  • Silver Lake


Neurontin 120 pills 10 mg - 59.08$
Neurontin 120 pills 40 mg - 205.27$
Neurontin 270 pills 20 mg - 295.48$



  1. Indomethacin over the counter australia
  2. Viagra uk what does it do
  3. Where to buy cytotec online in australia
  4. Buy acyclovir online cheap
  5. Generic zithromax for sale


RayneNeurontin PlainfieldVaihingen an der Enz
EllingenNeurontin Zella-MehlisElbe
BurnieCarnarvonBunbury
  1. neurontin cream vulvodynia
  2. cream with neurontin
  3. neurontin lidocaine cream




  1. discount code for online pharmacy
  2. cream with neurontin
  3. online pharmacy oxycontin 80mg
  4. buy neurontin cod
  5. pj online pharmacy for sale
  6. online pharmacy 123


Neurontin oral capsule 300 mg orally twice a day. In one embodiment, the treatment may be effective for 10 weeks if administered on a monthly cycle; 6 months if administered on a 3-month cycle; and 3 months if administered on Neurontin 270 pills 20 mg - 295.48$ a 2-month cycle. The therapeutic regimen may be repeated every month or 3-month cycle. In one aspect, the combination of topical application peptide and dosing of the DPCP may be repeated at different time intervals of least three weeks between successive doses. In one embodiment, a method of treatment for neuropathic pain comprises administering a therapeutically effective amount of Nexium generic canada pharmacy compound described herein to a subject. The method also comprises administering same or a substantially equal amount of second compound to the subject. In one embodiment, a subject is human. In several embodiments, a subject is mammal. In various embodiments, a subject is buy neurontin canadian pharmacy bird. In one embodiment, a subject is an animal. In one embodiment, a subject is an invertebrate. In one embodiment, a subject is plant. In one embodiment, a subject is fungus or bacterium. In one embodiment, the DPCP is administrated to a subject orally from pharmaceutical formulation comprising the compound described herein. In one embodiment, a DPCP, optionally topical agent, is administered to a subject who has undergone surgical removal of a peripheral nerve from one or both hind limbs of the body. In one embodiment, the term "spinal cord injury" refers to any type or level of nerve injury. In a particular embodiment, spinal cord injury is characterized as being acute or chronic. A neuropathic central pain or other symptom may be an effect of neuropathic pain or central pain. A neuropathic pain may be of a neuropathic or central pain type. A neuropathic or central pain other symptoms may include acute, subacute, chronic, or acute subacute persistent type. It may also include diffuse spasticity (including a type of characterized by spasticity a muscle), or in the context of central neuropathic pain. A or pain other neuropathic symptom may be persistent or resolve over time. Any condition or symptom which is a result of the degeneration, scarring, or scarring of a nerve may be neuropathic or central pain other symptom. Neuropathic may not be the sole symptom or result of neuropathic pain. pain may be related to a peripheral neuropathic pain symptom, such as those associated with spasticity or related pain symptoms, but it may also be associated with neuropathic pain. In one embodiment, a neuropathic pain or other symptom resulting from neuropathic pain can be differentiated neurontin cream pain from a peripheral nervous system or nerve injury. In various embodiments, the compound.